Huey-Jen L Lin

Title: Innovations of Huey-Jen L Lin in Oncogene Research

Introduction

Huey-Jen L Lin is a notable inventor based in Princeton, NJ (US). He has made significant contributions to the field of cancer research, particularly in understanding the mechanisms of oncogenes and their interaction with p53-mediated apoptosis. His work has implications for developing therapeutic strategies against cancer.

Latest Patents

Huey-Jen L Lin holds a patent for "Cells having oncogene-suppressed p53-mediated apoptosis and methods of." This invention outlines a method for determining if a compound can modulate the ability of a putative oncogene to suppress p53-mediated effects. The method involves adding a compound to genetically engineered cells that express specific gene products and examining the cells to determine whether apoptosis has occurred. This innovative approach provides valuable insights into cancer treatment.

Career Highlights

Lin is affiliated with Rutgers, the State University of New Jersey, where he continues to advance his research. His work has garnered attention for its potential to influence cancer therapies and improve patient outcomes. He has demonstrated a commitment to scientific excellence and innovation throughout his career.

Collaborations

Some of his notable coworkers include Eileen White and Shuin-Kwei Chiou. Their collaborative efforts contribute to the advancement of research in oncogene suppression and apoptosis.

Conclusion

Huey-Jen L Lin's contributions to the field of cancer research through his innovative patent highlight the importance of understanding oncogene interactions with p53. His work at Rutgers University continues to pave the way for future advancements in cancer therapies.